Martin Wygod Biography and Net Worth
Founder of Forian, Inc. and Medical Outcomes Research Analysis LLC, Max C. Wygod is Executive Chairman at Forian, Inc. and Executive Chairman at Medical Outcomes Research Analysis LLC (a subsidiary of Forian, Inc.).
He previously was Vice President-Business Development of WebMD Health Corp.
Max C. Wygod received an undergraduate degree from Duke University and an MBA from The Leonard N Stern School of Business.
What is Martin J. Wygod's net worth?
The estimated net worth of Martin J. Wygod is at least $140,735.00 as of May 30th, 2023. Mr. Wygod owns 56,294 shares of Forian stock worth more than $140,735 as of June 7th. This net worth approximation does not reflect any other assets that Mr. Wygod may own. Learn More about Martin J. Wygod's net worth.
Has Martin J. Wygod been buying or selling shares of Forian?
During the past quarter, Martin J. Wygod has bought $44,674.73 in Forian stock. Most recently, on Tuesday, May 30th, Martin J. Wygod bought 4,565 shares of Forian stock. The stock was acquired at an average cost of $2.39 per share, with a total value of $10,910.35. Following the completion of the transaction, the director now directly owns 56,294 shares of the company's stock, valued at $134,542.66. Learn More on Martin J. Wygod's trading history.
Who are Forian's active insiders?
Are insiders buying or selling shares of Forian?
During the last twelve months, Forian insiders bought shares 7 times. They purchased a total of 42,150 shares worth more than $123,347.88. The most recent insider tranaction occured on May, 30th when Director Martin J Wygod bought 4,565 shares worth more than $10,910.35. Insiders at Forian own 30.6% of the company.
Learn More about insider trades at Forian. Information on this page was last updated on 5/30/2023.
Martin J. Wygod Insider Trading History at Forian
Transaction Date | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
5/30/2023 | Buy | 4,565 | $2.39 | $10,910.35 | 56,294 | |
5/25/2023 | Buy | 3,000 | $2.34 | $7,020.00 | 51,729 | |
5/23/2023 | Buy | 5,999 | $2.38 | $14,277.62 | 47,402 | |
5/18/2023 | Buy | 5,444 | $2.29 | $12,466.76 | 41,403 | |
2/14/2023 | Buy | 10,485 | $3.91 | $40,996.35 | 35,959 | |
4/13/2022 | Buy | 2,030 | $4.67 | $9,480.10 | 22,324 | |
4/11/2022 | Buy | 3,059 | $5.02 | $15,356.18 | 14,261 | |
4/6/2022 | Buy | 202 | $5.41 | $1,092.82 | 11,202 | |
4/4/2022 | Buy | 3,000 | $6.46 | $19,380.00 | 3,000 | |
4/1/2022 | Buy | 6,827 | $6.68 | $45,604.36 | | |
3/30/2022 | Buy | 800 | $6.75 | $5,400.00 | | |
3/28/2022 | Buy | 3,200 | $6.41 | $20,512.00 | | |
2/14/2022 | Buy | 4,800 | $7.66 | $36,768.00 | | |
2/10/2022 | Buy | 4,800 | $7.92 | $38,016.00 | | |
1/21/2022 | Buy | 1,600 | $8.01 | $12,816.00 | | |
1/10/2022 | Buy | 3,200 | $7.81 | $24,992.00 | | |
12/15/2021 | Buy | 1,654 | $7.81 | $12,917.74 | | |
12/13/2021 | Buy | 6,678 | $7.94 | $53,023.32 | | |
12/10/2021 | Buy | 30 | $8.04 | $241.20 | | |
12/6/2021 | Buy | 6 | $8.14 | $48.84 | | |
12/3/2021 | Buy | 8,000 | $8.10 | $64,800.00 | | |
11/22/2021 | Buy | 455 | $9.20 | $4,186.00 | | |
11/17/2021 | Buy | 4,811 | $9.83 | $47,292.13 | | |
10/14/2021 | Buy | 9,002 | $10.04 | $90,380.08 | | |
10/5/2021 | Buy | 700 | $10.08 | $7,056.00 | | |
9/15/2021 | Buy | 7,844 | $9.94 | $77,969.36 | | |
9/13/2021 | Buy | 4,000 | $10.00 | $40,000.00 | | |
6/1/2021 | Buy | 1,300 | $9.95 | $12,935.00 | | |
5/25/2021 | Buy | 6,414 | $9.97 | $63,947.58 | | |
5/21/2021 | Buy | 8,000 | $9.95 | $79,600.00 | | |
5/19/2021 | Buy | 5,000 | $9.94 | $49,700.00 | | |
Forian Company Overview
Helix Technologies, Inc. (OTCQB: HLIX) is a provider of critical infrastructure services for the legal cannabis industry, helping owners and operators of licensed cannabis businesses stay competitive and compliant while mitigating risk in an ever-changing and expanding frontier market. Through our Critical Infrastructure Services Platform, Helix Technologies provides a unique suite of technology solutions to legal cannabis operators that facilitate compliant product movements on a global scale, providing confidence to governments, peace of mind to consumers, and access to a global cannabis supply chain. Our goal is to enable a truly global cannabis supply chain through technology that facilitates transparent and verifiable product movement across unique regulatory environments. We accomplish this through our platform, which is tailored to the unique needs of licensed cannabis operators seeking to overcome hurdles related to day to day operations management and new market expansion including tracking, compliance, product sourcing and verification, and business optimization.
Read More
Volume
3,284 shs
Average Volume
24,031 shs
Market Capitalization
$83.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.92